Ken Griffin Galera Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.17 - $3.0 $2,125 - $37,500
-12,500 Reduced 55.07%
10,200 $1,000
Q2 2023

Aug 14, 2023
BUY
$2.5 - $3.42 $53,000 - $72,504
21,200 Added 1413.33%
22,700 $70,000
Q1 2023

May 15, 2023
BUY
$1.48 - $2.68 $888 - $1,608
600 Added 66.67%
1,500 $3,000
Q4 2022

Feb 14, 2023
BUY
$1.34 - $1.78 $1,206 - $1,602
900 New
900 $1,000

Others Institutions Holding GRTX

# of Institutions
3
Shares Held
961K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.34M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email